Earnings and Growth Analysis : OpGen (NASDAQ:OPGN)

Earnings results for OpGen (NASDAQ:OPGN)

OpGen, Inc. is estimated to report earnings on 05/13/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.22. The reported EPS for the same quarter last year was $-0.43.

OpGen last posted its quarterly earnings data on March 24th, 2021. The medical research company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.06. The business earned $1.35 million during the quarter, compared to the consensus estimate of $1.30 million. OpGen has generated ($6.90) earnings per share over the last year. OpGen has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, May 13th, 2021 based off prior year’s report dates.

Analyst Opinion on OpGen (NASDAQ:OPGN)

2 Wall Street analysts have issued ratings and price targets for OpGen in the last 12 months. Their average twelve-month price target is $5.50, predicting that the stock has a possible upside of 142.29%. The high price target for OPGN is $7.00 and the low price target for OPGN is $4.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of “Buy.”

OpGen has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $5.50, OpGen has a forecasted upside of 142.3% from its current price of $2.27. OpGen has only been the subject of 2 research reports in the past 90 days.

Dividend Strength: OpGen (NASDAQ:OPGN)

OpGen does not currently pay a dividend. OpGen does not have a long track record of dividend growth.

Insiders buying/selling: OpGen (NASDAQ:OPGN)

In the past three months, OpGen insiders have not sold or bought any company stock. Only 0.36% of the stock of OpGen is held by insiders. Only 2.29% of the stock of OpGen is held by institutions.

Earnings and Valuation of OpGen (NASDAQ:OPGN

Earnings for OpGen are expected to grow in the coming year, from ($1.49) to ($1.06) per share. The P/E ratio of OpGen is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of OpGen is -1.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. OpGen has a P/B Ratio of 2.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here